Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Continuing Medical Education (CME) Grants

    Alnylam Pharmaceuticals' CME Grants fund independent, evidence-based education for healthcare professionals on ATTR amyloidosis, AHP, and PH1.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Educational Grants - Alnylam Pharmaceuticals

    Educational Grants - Alnylam Pharmaceuticals support healthcare professionals and patients through independent education on three rare diseases to advance earlier diagnosis, treatment decisions, and disease management.

    AlnylamRolling submissions

    Responses to Requests for Proposals

    Responses to Requests for Proposals supports organizations delivering independent education for healthcare professionals and patients to address knowledge gaps and improve care in ATTR amyloidosis, AHP, and PH1.

    AlnylamForecasted Oct 21, 2027$150,000Forecasted

    Sponsorships

    Alnylam Pharmaceuticals' Sponsorships fund educational and scientific initiatives advancing research and awareness in ATTR amyloidosis, AHP, and PH1.

    AlnylamRolling submissions

    Collaborations - Alnylam Pharmaceuticals

    Collaborations - Alnylam Pharmaceuticals supports external organizations in joint projects that advance education, ongoing research, and responses to community needs to improve patient health.

    AlnylamRolling submissions

    Charitable Donations

    Alnylam Pharmaceuticals' Charitable Donations support science and research initiatives by charitable organizations, with a focus on ATTR amyloidosis, AHP, and PH1.

    AlnylamRolling submissions$150,000